| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-16 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-14 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-12 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-12 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-11 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-11 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-11 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-10 |